双相障碍复杂网络中的微生物群-肠-脑轴机制:潜在临床意义与转化机会
本文综述双相障碍(BD)中微生物群-肠-脑(MGB)轴失调相关的病理生理机制及潜在治疗途径。MGB轴通过影响神经递质合成、HPA轴激活及免疫炎症反应参与BD病理网络,靶向肠道微生物群的干预(饮食、益生菌等)及精神药物对菌群的影响为改善临床管理提供新思路。
要点
- MGB轴失调可能通过神经递质、HPA轴和神经炎症参与BD病理生理。
- 靶向肠道菌群的干预(饮食、益生菌、益生元)具有治疗转化潜力。
- 需关注精神药物对肠道微生物群的影响及其临床意义。
核心结论
- MGB轴失调参与双相障碍的病理生理网络,靶向肠道微生物群可能为改善临床管理提供新治疗途径。
研究设计与样本
- 本文为综述,旨在阐明MGB轴失调衍生的病理生理机制及以肠道微生物群为重点的潜在治疗途径。
主要发现
- MGB轴对宿主神经调节和内分泌功能有强影响,包括控制5-羟色胺等神经递质合成或介导HPA轴激活。
- MGB轴调节宿主免疫反应,关键性调节肠道、全身及脑部炎症(神经炎症)。
临床怎么用
- 理解肠道微生物群与免疫等系统的双向通讯有助于发现改善双相障碍患者临床管理的新疗法。
- 可考虑饮食模式、益生菌、益生元等靶向肠道生态的治疗新方法。
- 需关注当前用于双相障碍患者的精神药物对肠道微生物群的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bipolar disorders (BD) represent a severe leading disabling mental condition worldwide characterized by episodic and often progressive mood fluctuations with manic and depressive stages. The biological mechanisms underlying the pathophysiology of BD remain incompletely understood, but it seems that there is a complex picture of genetic and environmental factors implicated. Nowadays, gut microbiota is in the spotlight of new research related to this kind of psychiatric disorder, as it can be consistently related to several pathophysiological events observed in BD. In the context of the so-called microbiota-gut-brain (MGB) axis, it is shown to have a strong influence on host neuromodulation and endocrine functions (i.e., controlling the synthesis of neurotransmitters like serotonin or mediating the activation of the hypothalamic-pituitary-adrenal axis), as well as in modulation of host immune responses, critically regulating intestinal, systemic and brain inflammation (neuroinflammation). The present review aims to elucidate pathophysiological mechanisms derived from the MGB axis disruption and possible therapeutic approaches mainly focusing on gut microbiota in the complex network of BD. Understanding the mechanisms of gut microbiota and its bidirectional communication with the immune and other systems can shed light on the discovery of new therapies for improving the clinical management of these patients. Besides, the effect of psychiatric drugs on gut microbiota currently used in BD patients, together with new therapeutical approaches targeting this ecosystem (dietary patterns, probiotics, prebiotics, and other novelties) will also be contemplated.
引用
- Ortega MA, Álvarez-Mon MA, García-Montero C, et al. Microbiota-gut-brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities. Mol Psychiatry. 2023. PMID: 36707651. doi:10.1038/s41380-023-01964-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。